Market Cap

Poseida Therapeutics, Inc. Market Capitalization:

$925.9 Million

USD as of Jan. 1, 2025

business Poseida Therapeutics, Inc. Company Profile

Poseida Therapeutics, Inc. Main Stock Listing

NASDAQ: PSTX

Market Capitalization History of Poseida Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Poseida Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $925.9 M 205.46%
Jan. 1, 2024 $303.1 M -50.95%
Jan. 1, 2023 $618.0 M 45.26%
Jan. 1, 2022 $425.4 M -45.40%
Jan. 1, 2021 $779.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Poseida Therapeutics, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Poseida Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: PSTX

Stock: FSX: 2RZ

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.